On the occasion of European Week Against Cancer (EWAC), taking place every year between 25 and 31 May, the World Bladder Cancer Patient Coalition (WBCPC) joins the community call for bringing forward the ambitions within Europe’s Beating Cancer Plan at the national and regional level.
The EWAC campaign and the Association of European Cancer Leagues (ECL) aim to highlight the role that each one of us has in accelerating the implementation of Europe’s Beating Cancer Plan.
The Global Cancer Coalitions Network (GCCN) is hosting a free virtual event on March 29, at 17:00 CEST, titled “Coalition Connection 3: Sustaining Patient Advocacy Post-Covid”.
Many patient advocacy organizations faced extraordinary challenges during the COVID-19 pandemic, from loss of crucial funding to significant reductions in human resources, both paid and unpaid.
As we look to a post-pandemic future, during the GCCN event you will hear three perspectives from:
• The advocacy world on how patient advocacy organizations coped with those challenges and what ‘silver linings’ they found;
The World Bladder Cancer Patient Coalition (WBCPC) was pleased to be present at Global Congress on Bladder Cancer 2021 on October 14-15 in Ghent (Belgium). It was also the first time WBCPC was participating at an event in-person since 2019. The theme and focus of the congress this year was turning new data into daily practices. The program consisted of state-of-the-art lectures, case discussions, and panel debates with international & multidisciplinary experts, including a session with bladder cancer patients and patient representatives.
The Global Cancer Coalitions Network (GCCN) is hosting a virtual event on November 23, at 13:00 CEST, titled “Coalition Connection 2: COVID19 Vaccines & Cancer”. A free online event that will cover the challenges that the COVID19 vaccine rollout has presented, not least for those already coping with a cancer diagnosis.
This event will be moderated by Alex Filicevas, Executive Director of WBCPC and it will seek to answer your potential questions from the perspectives of an Immunologist,
The Advocacy Exchange, a virtual platform created by Bristol Myers Squibb (BMS) and GRYT Health, unites advocacy organizations, patients, and members of the healthcare industry by sharing resources and best practices.
The upcoming discussion on this virtual platform is taking place on September 30, at 12:00 pm (ET), titled: “Giving Voice to the Often Voiceless: Advocate-led Research Creating Change” and Alex Filicevas, WBCPC Executive Director is invited and will be representing the voice of patients.